Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 529

1.

Avoiding, diagnosing and treating well leg compartment syndrome after pelvic surgery.

Gill M, Fligelstone L, Keating J, Jayne DG, Renton S, Shearman CP, Carlson GL; Association of Coloproctology of Great Britain and Ireland, the Vascular Society of Great Britain and Ireland, the British Orthopaedic Association and the British Association of Urological Surgeons.

Br J Surg. 2019 Aug;106(9):1156-1166. doi: 10.1002/bjs.11177. Review.

PMID:
31304580
2.

ANCA associated vasculitis: The journey to complement-targeted therapies.

Quintana LF, Kronbichler A, Blasco M, Zhao MH, Jayne D.

Mol Immunol. 2019 Jul 6;112:394-398. doi: 10.1016/j.molimm.2019.06.018. [Epub ahead of print] Review.

PMID:
31291610
3.

The Longitudinal Course of Fatigue in Anca Associated Vasculitis.

O'Malley L, Druce K, Chanouzas D, Morgan M, Jones R, Jayne D, Basu N, Harper L.

J Rheumatol. 2019 Jul 1. pii: jrheum.190113. doi: 10.3899/jrheum.190113. [Epub ahead of print]

PMID:
31263068
4.

Relationship between surgeons and industry.

Jayne DG.

Br J Surg. 2019 Jul;106(8):965-967. doi: 10.1002/bjs.11241. No abstract available.

PMID:
31260581
5.

Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis.

Teixeira V, Mohammad AJ, Jones RB, Smith R, Jayne D.

RMD Open. 2019 Jun 5;5(1):e000905. doi: 10.1136/rmdopen-2019-000905. eCollection 2019.

6.

Preclinical evaluation of porcine colon resection using hollow core negative curvature fibre delivered ultrafast laser pulses.

Mohanan SMPC, Beck RJ, West NP, Shires M, Perry SL, Jayne DG, Hand DP, Shephard JD.

J Biophotonics. 2019 Jun 26:e201900055. doi: 10.1002/jbio.201900055. [Epub ahead of print]

PMID:
31240824
7.

Response to: 'Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Jones et al' by Vandergheynst et al.

Jones RB, Hiemstra TF, Walsh M, Jayne D, Harper L.

Ann Rheum Dis. 2019 Jun 19. pii: annrheumdis-2019-215658. doi: 10.1136/annrheumdis-2019-215658. [Epub ahead of print] No abstract available.

PMID:
31217171
8.

Factors supporting and constraining the implementation of robot-assisted surgery: a realist interview study.

Randell R, Honey S, Alvarado N, Greenhalgh J, Hindmarsh J, Pearman A, Jayne D, Gardner P, Gill A, Kotze A, Dowding D.

BMJ Open. 2019 Jun 14;9(6):e028635. doi: 10.1136/bmjopen-2018-028635.

9.

Comment on "Is Dedicated Research Time During Surgery Residency Associated With Surgeons' Future Career Paths?: A National Study".

Bolton WS, Waduud M, Bailey MA, Scott J, Jayne DG.

Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003410. [Epub ahead of print] No abstract available.

PMID:
31188220
10.

Anal fistula plug versus surgeon's preference for surgery for trans-sphincteric anal fistula: the FIAT RCT.

Jayne DG, Scholefield J, Tolan D, Gray R, Edlin R, Hulme CT, Sutton AJ, Handley K, Hewitt CA, Kaur M, Magill L.

Health Technol Assess. 2019 May;23(21):1-76. doi: 10.3310/hta23210.

11.

Rituximab as maintenance treatment for systemic Lupus Erythematosus: a multicentre observational study of 147 patients.

Cassia MA, Alberici F, Jones RB, Smith RM, Casazza G, Urban ML, Emmi G, Moroni G, Sinico RA, Messa P, Hall F, Vaglio A, Gallieni M, Jayne DR.

Arthritis Rheumatol. 2019 May 18. doi: 10.1002/art.40932. [Epub ahead of print]

12.

Outcome of participants with nephrotic syndrome in combined clinical trials of lupus nephritis.

Gomez Mendez LM, Cascino MD, Katsumoto TR, Brakeman P, Brunetta P, Jayne D, Dall'Era M, Rovin B, Garg J.

Lupus Sci Med. 2019 Feb 4;6(1):e000308. doi: 10.1136/lupus-2018-000308. eCollection 2019.

13.

Keratinocyte growth factor impairs human thymic recovery from lymphopenia.

Coles AJ, Azzopardi L, Kousin-Ezewu O, Mullay HK, Thompson SA, Jarvis L, Davies J, Howlett S, Rainbow D, Babar J, Sadler TJ, Brown JWL, Needham E, May K, Georgieva ZG, Handel AE, Maio S, Deadman M, Rota I, Holländer G, Dawson S, Jayne D, Seggewiss-Bernhardt R, Douek DC, Isaacs JD, Jones JL.

JCI Insight. 2019 May 7;5. pii: 125377. doi: 10.1172/jci.insight.125377.

14.

Subclassifying ANCA-associated vasculitis: a unifying view of disease spectrum.

Mahr A, Specks U, Jayne D.

Rheumatology (Oxford). 2019 May 3. pii: kez148. doi: 10.1093/rheumatology/kez148. [Epub ahead of print] No abstract available.

PMID:
31049594
15.

The current status of phototherapy in multimodal anti-cancer nanomedicines.

Khot MI, Armstrong G, Andrew H, Downey CL, Jayne DG.

Photodiagnosis Photodyn Ther. 2019 Jun;26:350. doi: 10.1016/j.pdpdt.2019.04.024. Epub 2019 Apr 28. No abstract available.

PMID:
31042555
16.

Current concepts in imaging for local staging of advanced rectal cancer.

Brown PJ, Hyland R, Quyn AJ, West NP, Sebag-Montefiore D, Jayne D, Sagar P, Tolan DJ.

Clin Radiol. 2019 Aug;74(8):623-636. doi: 10.1016/j.crad.2019.03.023. Epub 2019 Apr 26. Review.

PMID:
31036310
17.

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.

Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, Houssiau F, Jayne D, Kouloumas M, Kuhn A, Larsen JL, Lerstrøm K, Moroni G, Mosca M, Schneider M, Smolen JS, Svenungsson E, Tesar V, Tincani A, Troldborg A, van Vollenhoven R, Wenzel J, Bertsias G, Boumpas DT.

Ann Rheum Dis. 2019 Jun;78(6):736-745. doi: 10.1136/annrheumdis-2019-215089. Epub 2019 Mar 29.

PMID:
30926722
18.

Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis.

McClure ME, Wason J, Gopaluni S, Tieu J, Smith RM, Jayne DR, Jones RB.

J Clin Rheumatol. 2019 Mar 20. doi: 10.1097/RHU.0000000000001030. [Epub ahead of print]

PMID:
30896460
19.

A Review on the Scope of Photothermal Therapy-Based Nanomedicines in Preclinical Models of Colorectal Cancer.

Khot MI, Andrew H, Svavarsdottir HS, Armstrong G, Quyn AJ, Jayne DG.

Clin Colorectal Cancer. 2019 Jun;18(2):e200-e209. doi: 10.1016/j.clcc.2019.02.001. Epub 2019 Feb 14. Review.

PMID:
30852125
20.

Visual loss in giant cell arteritis 3 weeks after steroid initiation.

Le Goueff A, Peters J, Willcocks L, Jayne D.

BMJ Case Rep. 2019 Mar 6;12(3). pii: e228251. doi: 10.1136/bcr-2018-228251.

PMID:
30846454
21.

Immunoglobulin replacement for secondary immunodeficiency after B-cell targeted therapies in autoimmune rheumatic disease: Systematic literature review.

Wijetilleka S, Mukhtyar C, Jayne D, Ala A, Bright P, Chinoy H, Harper L, Kazmi M, Kiani-Alikhan S, Li C, Misbah S, Oni L, Price-Kuehne F, Salama A, Workman S, Wrench D, Karim MY.

Autoimmun Rev. 2019 May;18(5):535-541. doi: 10.1016/j.autrev.2019.03.010. Epub 2019 Mar 4.

PMID:
30844552
22.

Refractory lupus nephritis: When, why and how to treat.

Kronbichler A, Brezina B, Gauckler P, Quintana LF, Jayne DRW.

Autoimmun Rev. 2019 May;18(5):510-518. doi: 10.1016/j.autrev.2019.03.004. Epub 2019 Mar 4. Review.

PMID:
30844548
23.

Systemic vasculitis and patient-reported outcomes: how the assessment of patient preferences and perspectives could improve outcomes.

Robson JC, Jayne D, Merkel PA, Dawson J.

Patient Relat Outcome Meas. 2019 Feb 8;10:37-42. doi: 10.2147/PROM.S163601. eCollection 2019. Review.

24.

Genetic Variants in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Bayesian Approach and Systematic Review.

Lee KS, Kronbichler A, Pereira Vasconcelos DF, Pereira da Silva FR, Ko Y, Oh YS, Eisenhut M, Merkel PA, Jayne D, Amos CI, Siminovitch KA, Rahmattulla C, Lee KH, Shin JI.

J Clin Med. 2019 Feb 21;8(2). pii: E266. doi: 10.3390/jcm8020266.

25.

Rectal Surgery Evaluation Trial: protocol for a parallel cohort trial of outcomes using surgical techniques for total mesorectal excision with low anterior resection in high-risk rectal cancer patients.

Rouanet P, Gourgou S, Gogenur I, Jayne D, Ulrich A, Rautio T, Spinoglio G, Bouazza N, Moussion A, Gomez Ruiz M.

Colorectal Dis. 2019 May;21(5):516-522. doi: 10.1111/codi.14581. Epub 2019 Mar 14.

PMID:
30740878
26.

Response to: 'Prevention of infections in patients with antineutrophil cytoplasm antibody-associated vasculitis: potential role of hydroxychloroquine' by Novikov et al.

Kronbichler A, Jayne D.

Ann Rheum Dis. 2019 Jan 30. pii: annrheumdis-2018-214735. doi: 10.1136/annrheumdis-2018-214735. [Epub ahead of print] No abstract available.

PMID:
30700426
27.

Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus.

Tedeschi SK, Johnson SR, Boumpas DT, Daikh D, Dörner T, Diamond B, Jacobsen S, Jayne D, Kamen DL, McCune WJ, Mosca M, Ramsey-Goldman R, Ruiz-Irastorza G, Schneider M, Urowitz M, Wofsy D, Smolen JS, Naden RP, Aringer M, Costenbader KH.

Ann Rheum Dis. 2019 May;78(5):634-640. doi: 10.1136/annrheumdis-2018-214685. Epub 2019 Jan 28.

28.

A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis.

Pepper RJ, McAdoo SP, Moran SM, Kelly D, Scott J, Hamour S, Burns A, Griffith M, Galliford J, Levy JB, Cairns TD, Gopaluni S, Jones RB, Jayne D, Little MA, Pusey CD, Salama AD.

Rheumatology (Oxford). 2019 Feb 1;58(2):373. doi: 10.1093/rheumatology/kez001. No abstract available.

PMID:
30690635
29.

Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study.

Jayne D, Blockmans D, Luqmani R, Moiseev S, Ji B, Green Y, Hall L, Roth D, Henderson RB, Merkel PA.

Arthritis Rheumatol. 2019 Jun;71(6):952-963. doi: 10.1002/art.40802. Epub 2019 Apr 16.

30.

Comment on: A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis: reply.

Pepper R, Jayne D, Little M, Pusey C, Salama AD.

Rheumatology (Oxford). 2019 Apr 1;58(4):738-739. doi: 10.1093/rheumatology/key388. No abstract available.

PMID:
30649464
31.

Estimating the epidemiology of anti-neutrophil cytoplasm antibody-associated renal vasculitis and the role of histologic chronicity in predicting renal outcomes.

Kronbichler A, Jayne DRW.

Nephrol Dial Transplant. 2019 Jan 14. doi: 10.1093/ndt/gfy402. [Epub ahead of print] No abstract available.

PMID:
30649435
32.

Disseminating technology in global surgery.

Bolton WS, Aruparayil N, Quyn A, Scott J, Wood A, Bundu I, Gnanaraj J, Brown JM, Jayne DG.

Br J Surg. 2019 Jan;106(2):e34-e43. doi: 10.1002/bjs.11036. Review.

PMID:
30620068
33.

Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial.

Jones RB, Hiemstra TF, Ballarin J, Blockmans DE, Brogan P, Bruchfeld A, Cid MC, Dahlsveen K, de Zoysa J, Espigol-Frigolé G, Lanyon P, Peh CA, Tesar V, Vaglio A, Walsh M, Walsh D, Walters G, Harper L, Jayne D; European Vasculitis Study Group (EUVAS).

Ann Rheum Dis. 2019 Mar;78(3):399-405. doi: 10.1136/annrheumdis-2018-214245. Epub 2019 Jan 5.

PMID:
30612116
34.

Re: 'ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies' by Mikulska et al.

Wijetilleka S, Jayne D, Mukhtyar C, Karim MY.

Clin Microbiol Infect. 2019 Apr;25(4):531-532. doi: 10.1016/j.cmi.2018.12.025. Epub 2018 Dec 27. No abstract available.

PMID:
30594651
35.

Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases.

Wijetilleka S, Jayne DR, Mukhtyar C, Ala A, Bright PD, Chinoy H, Harper L, Kazmi MA, Kiani-Alikhan S, Li CK, Misbah SA, Oni L, Price-Kuehne FE, Salama AD, Workman S, Wrench D, Karim MY.

Rheumatology (Oxford). 2018 Dec 26. doi: 10.1093/rheumatology/key394. [Epub ahead of print]

PMID:
30590695
36.

Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis.

Steinfeld J, Bradford ES, Brown J, Mallett S, Yancey SW, Akuthota P, Cid MC, Gleich GJ, Jayne D, Khoury P, Langford CA, Merkel PA, Moosig F, Specks U, Weller PF, Wechsler ME.

J Allergy Clin Immunol. 2019 Jun;143(6):2170-2177. doi: 10.1016/j.jaci.2018.11.041. Epub 2018 Dec 19.

PMID:
30578883
37.

Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria.

Johnson SR, Khanna D, Daikh D, Cervera R, Costedoat-Chalumeau N, Gladman DD, Hahn BH, Hiepe F, Sánchez-Guerrero J, Massarotti E, Boumpas DT, Costenbader KH, Jayne D, Dörner T, Kamen DL, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Aringer M.

J Rheumatol. 2019 Jul;46(7):721-726. doi: 10.3899/jrheum.180478. Epub 2018 Dec 15.

PMID:
30554156
38.

Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome.

Wester Trejo MAC, Floßmann O, Westman KW, Höglund P, Hagen EC, Walsh M, Bruijn JA, Jayne DRW, Bajema IM, Berden AE.

Rheumatology (Oxford). 2019 Jan 1;58(1):103-109. doi: 10.1093/rheumatology/key260.

PMID:
30551161
39.
40.

Preface.

Luqmani RA, Jayne D.

Best Pract Res Clin Rheumatol. 2018 Feb;32(1):1-2. doi: 10.1016/j.berh.2018.11.001. No abstract available.

PMID:
30526890
41.

Is patient-specific pre-operative preparation feasible in a clinical environment? A systematic review and meta-analysis.

Yiasemidou M, Glassman D, Jayne D, Miskovic D.

Comput Assist Surg (Abingdon). 2018 Dec;23(1):57-68. doi: 10.1080/24699322.2018.1495266.

PMID:
30497290
42.

European consensus on the standardization of robotic total mesorectal excision for rectal cancer.

Miskovic D, Ahmed J, Bissett-Amess R, Gómez Ruiz M, Luca F, Jayne D, Figueiredo N, Heald RJ, Spinoglio G, Parvaiz A; European Academy for Robotic Colorectal Surgery (EARCS).

Colorectal Dis. 2019 Mar;21(3):270-276. doi: 10.1111/codi.14502. Epub 2019 Jan 24.

PMID:
30489676
43.

Systematic Review and Meta-analysis of Nonsteroidal Anti-inflammatory Drugs to Improve GI Recovery After Colorectal Surgery.

Chapman SJ, Garner JJ, Drake TM, Aldaffaa M, Jayne DG.

Dis Colon Rectum. 2019 Feb;62(2):248-256. doi: 10.1097/DCR.0000000000001281.

PMID:
30489321
44.

ANCA Renal Risk Score: is prediction of end-stage renal disease at baseline possible?

Kronbichler A, Jayne DRW.

Kidney Int. 2018 Dec;94(6):1045-1047. doi: 10.1016/j.kint.2018.10.001.

PMID:
30466561
45.

The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritis.

Mertz P, Belot A, Cervera R, Chuah TY, Dagna L, Damian L, Danda D, D'cruz D, Espinosa G, Frances C, Jayne D, Ooi KK, Kucharz EJ, Lebovics R, Marie I, Moulis G, Peng S, Sharma A, Suzuki N, Tanaka T, Van Vollenhoven R, Sibilia J, Gottenberg JE, Chasset F, Arnaud L.

Joint Bone Spine. 2019 May;86(3):363-368. doi: 10.1016/j.jbspin.2018.11.001. Epub 2018 Nov 15.

PMID:
30448476
46.

Effect of Disease Activity at Three and Six Months After Diagnosis on Long-Term Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Gopaluni S, Flossmann O, Little MA, O'Hara P, Bekker P, Jayne D; European Vasculitis Society.

Arthritis Rheumatol. 2019 May;71(5):784-791. doi: 10.1002/art.40776. Epub 2019 Mar 28.

PMID:
30418705
47.

Nasal carriage of Staphylococcus pseudintermedius in patients with granulomatosis with polyangiitis.

Kronbichler A, Blane B, Holmes MA, Wagner J, Parkhill J, Peacock SJ, Jayne DRW, Harrison EM.

Rheumatology (Oxford). 2019 Mar 1;58(3):548-550. doi: 10.1093/rheumatology/key317. No abstract available.

48.

Publisher Correction: B cell therapy in ANCA-associated vasculitis: current and emerging treatment options.

McClure M, Gopaluni S, Jayne D, Jones R.

Nat Rev Rheumatol. 2018 Dec;14(12):741. doi: 10.1038/s41584-018-0116-3.

PMID:
30390047
49.

Stimuli-Responsive Release of Antimicrobials Using Hybrid Inorganic Nanoparticle-Associated Drug-Delivery Systems.

Moorcroft SCT, Jayne DG, Evans SD, Ong ZY.

Macromol Biosci. 2018 Dec;18(12):e1800207. doi: 10.1002/mabi.201800207. Epub 2018 Oct 14. Review.

PMID:
30318831
50.

A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis.

Pepper RJ, McAdoo SP, Moran SM, Kelly D, Scott J, Hamour S, Burns A, Griffith M, Galliford J, Levy JB, Cairns TD, Gopaluni S, Jones RB, Jayne D, Little MA, Pusey CD, Salama AD.

Rheumatology (Oxford). 2019 Feb 1;58(2):260-268. doi: 10.1093/rheumatology/key288.

PMID:
30239910

Supplemental Content

Support Center